Overview

An Adaptive Treatment Strategy for Adolescent Depression-Continuation

Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
Aim 1: Assess the feasibility and acceptability of the personalized continuation treatment strategy. Aim 2: Estimate variances of primary and secondary outcomes with the continuation treatment. Aim 3: Conduct exploratory hypothesis-generating analyses to inform further development of the personalized continuation treatment strategy to be tested in a subsequent R01 proposal.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Collaborator:
University of Minnesota, MN
Treatments:
Fluoxetine